Clinical Trial

Hoffa's Fat Pad Impingement (HFPI)

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The aim of the study is to investigate treatment outcomes for refractory anterior knee pain due to Hoffa's Fat Pad Impingement (HFPI) in young female athletes. Specifically, the study team will study pediatric female athletes with HFPI, and treatment outcomes of US-guided Hoffa's Fat Pad (HFP) corticosteroid injection compared to standard care (physical therapy, bracing, no injection) and saline injection. There will be two arms in this study, 1, a corticosteroid injection and physical therapy and 2, physical therapy and a saline injection. The intent of this study is to measure treatment outcomes, and the research team is not looking at the safety and effectiveness of the lidocaine-methylprednisolone mixture.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-20; most recent amendment 2026-03-19.
Status change: Not Yet Recruiting → Recruiting 2026-03-19
Trial Details
NCT Number NCT07255248
Lead Sponsor Boston Children's Hospital
Conditions Hoffa's Fat Pad Impingement
Enrollment 62 participants
Start Date 2026-03-01
Primary Completion 2027-11-01 (estimated)
Study Completion 2028-01-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-23